SynthesisDiabetologia2009
Cardiovascular risk assessment scores for people with diabetes: a systematic review.
Synthesis in Diabetologia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
72 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Pooled it
- Tools for Assessing Cardiovascular Disease Risk Factors in Underserved Young Adult Populations: A Systematic Review.International journal of environmental research and public health · 2021Pooled it
- Predicting the risk of stroke among patients with type 2 diabetes: a systematic review and meta-analysis of C-statistics.BMJ open · 2019Pooled it
- Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2017Pooled it
- Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative.Diabetologia · 2013Pooled it
- Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks.Radiation oncology (London, England) · 2020Trial
- Use of a Metabolic Syndrome SeverityDiabetes care · 2018Trial
- A Multidisciplinary Intervention Utilizing Virtual Communication Tools to Reduce Health Disparities: A Pilot Randomized Controlled Trial.International journal of environmental research and public health · 2015Trial
- Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects.BioMed research international · 2015Trial
- Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial.Diabetic medicine : a journal of the British Diabetic Association · 2014Trial
- Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014Trial
- Trial
- Trial
- Pressure Injury Risk Assessment in Nursing Practice: A Head-to-Head Comparison of the Braden Scale and Machine Learning Models.Journal of clinical medicine · 2026Article
- Depression severity and cardiovascular risk in patients with type 2 diabetes mellitus: insights from the framingham risk score.Scientific reports · 2026Article
- An interpretable machine learning model for predicting 1-year major adverse cardiovascular events in patients with type 2 diabetes and hypertension.Frontiers in medicine · 2026Article
- A Review of Emerging Biomarkers Connecting Diabetes and Ischemic Stroke: Implications for Early Detection and Risk Stratification.Journal of diabetes research · 2026Review
- Article
- Machine learning for predicting cardiovascular events in older adults with type 2 diabetes using Medicare claims and electronic health records.Journal of clinical epidemiology · 2025Article
- Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.Diabetologia · 2025Review
12 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
People with type 2 diabetes have an increased risk of cardiovascular disease (CVD). Multivariate cardiovascular risk scores have been used in many countries to identify individuals who are at high risk of CVD. These risk scores include those originally developed in individuals with diabetes and those developed in a general population. This article reviews the published evidence for the performance of CVD risk scores in diabetic patients by: (1) examining the overall rationale for using risk scores; (2) systematically reviewing the literature on available scores; and (3) exploring methodological issues surrounding the development, validation and comparison of risk scores. The predictive performance of cardiovascular risk scores varies substantially between different populations. There is little evidence to suggest that risk scores developed in individuals with diabetes estimate cardiovascular risk more accurately than those developed in the general population. The inconsistency in the methods used in evaluation studies makes it difficult to compare and summarise the predictive ability of risk scores. Overall, CVD risk scores rank individuals reasonably accurately and are therefore useful in the management of diabetes with regard to targeting therapy to patients at highest risk. However, due to the uncertainty in estimation of true risk, care is needed when using scores to communicate absolute CVD risk to individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.